# TEMPORAL CLINICAL REASONING ENGINE (TCRE)
# ENGINEERING INVENTION TECHNICAL SPECIFICATION (EITS)
# VOLUME 2 – MATHEMATICAL FRAMEWORK & TEMPORAL REASONING FORMALIZATION

---

## DOCUMENT METADATA SHEET

*   **Document Title:** EITS Volume 2 – Mathematical Framework & Temporal Reasoning Formalization
*   **Document Type:** Engineering Mathematical Monograph
*   **Document Version:** 1.0 (Frozen Master Reference)
*   **Associated Software Version:** 2.1.0
*   **Status:** Frozen Master Reference
*   **Classification:** Restrictive / Clinical Engineering Internal
*   **Prepared By:** Lead Applied Mathematician, Clinical Data Scientist, and Systems Engineer
*   **Reviewed By:** Internal Engineering Review (Author Review Complete)
*   **Approval Status:** Internal Technical Approval (Pending External Peer Review)
*   **Associated Volumes:** 
    *   Volume 0 – System Architecture Specification (Frozen Reference)
    *   Volume 1 – Problem Definition, Clinical Context, Design Philosophy & Conceptual Architecture (Frozen Reference)

---

## 0. TABLE OF CONTENTS

1. [Chapter 1: Mathematical Foundations & General Framework](#chapter-1-mathematical-foundations--general-framework)
2. [Chapter 2: Mathematical Dependency Graph](#chapter-2-mathematical-dependency-graph)
3. [Chapter 3: Global Symbol Dictionary](#chapter-3-global-symbol-dictionary)
4. [Chapter 4: Units and Dimensional Analysis](#chapter-4-units-and-dimensional-analysis)
5. [Chapter 5: Parameter Reference Table](#chapter-5-parameter-reference-table)
6. [Chapter 6: Telemetry Mathematical Model](#chapter-6-telemetry-mathematical-model)
7. [Chapter 7: Temporal Metric Formulation](#chapter-7-temporal-metric-formulation)
8. [Chapter 8: Normalization and Scaling Theory](#chapter-8-normalization-and-scaling-theory)
9. [Chapter 9: Latent State Mathematical Formulation](#chapter-9-latent-state-mathematical-formulation)
10. [Chapter 10: Composite State Mathematical Formulation](#chapter-10-composite-state-mathematical-formulation)
11. [Chapter 11: Risk Synthesis & Recommendation Prioritization Mathematics](#chapter-11-risk-synthesis--recommendation-prioritization-mathematics)
12. [Chapter 12: Prediction, Trajectory, and Digital Twin Mathematics](#chapter-12-prediction-trajectory-and-digital-twin-mathematics)
13. [Chapter 13: Mathematical Invariants & Numerical Stability](#chapter-13-mathematical-invariants--numerical-stability)
14. [Chapter 14: Computational Complexity](#chapter-14-computational-complexity)
15. [Chapter 15: Calibration Theory, Error Propagation, & Sensitivity Analysis](#chapter-15-calibration-theory-error-propagation--sensitivity-analysis)
16. [Chapter 16: Mathematical Justifications & Biomarker Generalization](#chapter-16-mathematical-justifications--biomarker-generalization)
17. [Chapter 17: Fully Worked Numerical Examples](#chapter-17-fully-worked-numerical-examples)
18. [Chapter 18: Summary](#chapter-18-summary)

---

## CHAPTER 1: MATHEMATICAL FOUNDATIONS & GENERAL FRAMEWORK

### 1.1 Discrete Time-Series Signal Representation
Physiological processes operate in continuous time, generating biological signals that fluctuate dynamically. However, electronic telemetry systems capture these signals as discrete sequences of measurements. 

Let the continuous physiological signal of interest be represented by the function:
\[f(t) \in \mathbb{R},\quad t \in [T_{start}, T_{end}]\]
In practice, a sensor samples this signal at discrete times \(t_i\), yielding a telemetry sequence:
\[M = \{(t_0, y_0), (t_1, y_1), \dots, (t_{N-1}, y_{N-1})\}\]
where \(y_i = f(t_i) + \epsilon_i\) represents the measured value at timestamp \(t_i\), and \(\epsilon_i \sim \mathcal{N}(0, \sigma^2)\) represents the combined sensor and physiological noise.

### 1.2 The General Mathematical Operator Pipeline
The TCRE maps raw telemetry sequences \(M\) to validated decision support using a sequence of five mathematical transition operators:
\[M \xrightarrow{\Phi} I \xrightarrow{\Theta} S_L \xrightarrow{\Lambda} S_C \xrightarrow{\Psi} R \xrightarrow{\Omega} \mathbf{Rec}\]

Where:
1.  **Temporal Feature Operator (\(\Phi\)):** Maps the raw discrete telemetry dataset \(M\) to a set of six normalized temporal indices \(I = \{VI, AI, VOL, BDI, CBI, SCI\}\):
    \[\Phi(M) \to I\]
2.  **Latent State Gating Operator (\(\Theta\)):** Maps the indices \(I\) to the scores and status vectors of the eight latent clinical states \(S_L = \{SD, FR, CB, HV, RD, TC, TNR, SC\}\) by evaluating Boolean logic gates:
    \[\Theta(I) \to S_L\]
3.  **Composite Gating Operator (\(\Lambda\)):** Synthesizes multi-state clinical interactions to output active composite crisis profiles \(S_C = \{CC, HE, RD_{comp}, UP, EC\}\):
    \[\Lambda(S_L) \to S_C\]
4.  **Risk Synthesis Operator (\(\Psi\)):** Weights indices, latent states, and composite crisis profiles to calculate the metabolic risk score \(R_{final}\) and trend classification:
    \[\Psi(I, S_L, S_C) \to R_{final}\]
5.  **Recommendation Mapping Operator (\(\Omega\)):** Maps active states and risk levels to prioritized clinician guidelines:
    \[\Omega(S_L, S_C, R_{final}) \to \mathbf{Rec}\]

This sequence defines the formal mathematical identity of the TCRE.

---

### CHAPTER 1: CONCLUSION

#### Key Engineering Insights
*   Physiological telemetry consists of noisy, discrete observations of a continuous, latent homeostatic system.
*   The TCRE uses a sequence of five transition operators to map raw telemetry to validated recommendations.
*   This structured pipeline isolates calculations, ensuring determinism and traceability.

#### Design Considerations
*   Interfaces between operators must use strongly-typed data structures to support modularity.
*   All calculations must run synchronously to ensure that decision support outputs are available for review.

#### Assumptions
*   It is assumed that the incoming telemetry stream is chronologically sorted:
    \[t_0 < t_1 < \dots < t_{N-1}\]
*   It is assumed that physiological noise \(\epsilon_i\) is zero-mean over long observation windows.

#### Boundary Conditions
*   If a transition operator fails or returns an error, the pipeline must halt and output a system error status.
*   Calculations are restricted to the selected observation window.

#### Transition to the Next Chapter
Having defined the general mathematical pipeline, the next chapter will outline the mathematical dependency graph of the TCRE.

---

## CHAPTER 2: MATHEMATICAL DEPENDENCY GRAPH

### 2.1 Codebase Ingestion and Calculation Dependencies
The mathematical dependency graph maps the chronological flow of data transformations through the TCRE pipeline, tracing raw telemetry inputs to validated clinical recommendations.

```
                  +-----------------------------------+
                  |       Raw Measurements (M)        |
                  +-----------------+-----------------+
                                    |
                                    v (Signal parsing & sorting)
                  +-----------------+-----------------+
                  |         Signal Processing         |
                  +-----------------+-----------------+
                                    |
                                    v (Linear regression fits)
                  +-----------------+-----------------+
                  |         Regression (S)            |
                  +-----------------+-----------------+
                                    |
                                    v (Mathematical metrics)
                  +-----------------+-----------------+
                  |      Temporal Metrics (I)         |
                  +-----------------+-----------------+
                                    |
                                    v (Clamping & offsets)
                  +-----------------+-----------------+
                  |         Normalization             |
                  +-----------------+-----------------+
                                    |
                                    v (Boolean logic gates)
                  +-----------------+-----------------+
                  |         Latent States (S_L)       |
                  +-----------------+-----------------+
                                    |
                                    v (Multi-state interaction rules)
                  +-----------------+-----------------+
                  |       Composite States (S_C)      |
                  +-----------------+-----------------+
                                    |
                                    v (Weighted raw risk sums)
                  +-----------------+-----------------+
                  |          Risk Score (R)           |
                  +-----------------+-----------------+
                                    |
                                    v (Guideline selection maps)
                  +-----------------+-----------------+
                  |         Recommendations           |
                  +-----------------+-----------------+
                                    |
                                    v (Markov path predictions)
                  +-----------------+-----------------+
                  |           Prediction              |
                  +-----------------+-----------------+
                                    |
                                    v (Modifier simulations)
                  +-----------------+-----------------+
                  |          Digital Twin             |
                  +-----------------+-----------------+
                                    |
                                    v (8 consistency layers checks)
                  +-----------------+-----------------+
                  |           Validation              |
                  +-----------------------------------+
```

---

### CHAPTER 2: CONCLUSION

#### Key Engineering Insights
*   The dependency graph maps the flow of data transformations from raw inputs to validated outputs.
*   Data flows in a single direction, facilitating testing, debugging, and verification.
*   The validation layer audits all transformations to ensure consistency.

#### Design Considerations
*   Interfaces between layers must use strict, strongly-typed JSON schemas.
*   Calculation outputs at each layer must remain immutable once generated.

#### Assumptions
*   It is assumed that the client application runtime handles page rendering asynchronously, allowing calculations in the reasoning layers to run to completion first.
*   It is assumed that all configuration-dependent thresholds are loaded into memory before the reasoning cycle begins.

#### Boundary Conditions
*   If a layer fails, the pipeline must halt and output a system error status.
*   Telemetry records must contain valid timestamps to allow calculation of baseline drifts.

#### Transition to the Next Chapter
Having detailed the dependency graph, the next chapter will present the global symbol dictionary.

---

## CHAPTER 3: GLOBAL SYMBOL DICTIONARY

### 3.1 Notation Dictionary Matrix
Table 3.1 lists the mathematical symbols, variables, indices, and functions used in the TCRE mathematical monograph.

| Symbol | Meaning | Units | Range | Chapter Introduced | Used By |
| :---: | :--- | :--- | :---: | :---: | :--- |
| \(t_i\) | Timestamp of measurement \(i\) | Seconds | \(\mathbb{R}^+\) | Chapter 2 | Ingestion, Time Deltas |
| \(\Delta t\) | Spacing time delta | Seconds | \(\mathbb{R}^+\) | Chapter 2 | Telemetry Model |
| \(N\) | Count of measurements | Dimensionless | \([0, \infty)\) | Chapter 2 | Ingestion, Volatility, SCI |
| \(\mu\) | Mean biomarker value | mg/dL | \([50, 600]\) | Chapter 3 | BDI, Chronic Burden |
| \(\sigma\) | Standard deviation of residuals | mg/dL | \([0, \infty)\) | Chapter 3 | Volatility, Sensitivity |
| \(RMSE\) | Root Mean Square Error | mg/dL | \([0, \infty)\) | Chapter 3 | Volatility Index |
| \(S\) | Slope of linear regression | mg/dL/day | \([-5.0, 7.5]\) | Chapter 3 | Velocity, Acceleration |
| \(VI\) | Velocity Index | Dimensionless | \([0, 100]\) | Chapter 3 | Latent Rules, Risk Synthesis |
| \(AI\) | Acceleration Index | Dimensionless | \([0, 100]\) | Chapter 3 | Latent Rules, Risk Synthesis |
| \(VOL\) | Volatility Index | Dimensionless | \([0, 100]\) | Chapter 3 | Latent Rules, Risk Synthesis |
| \(BDI\) | Baseline Deviation Index | Dimensionless | \([0, 100]\) | Chapter 3 | Latent Rules, Risk Synthesis |
| \(CBI\) | Cumulative Burden Index | Dimensionless | \([0, 100]\) | Chapter 3 | Latent Rules, Risk Synthesis |
| \(SCI\) | State Confidence Index | Dimensionless | \([0, 100]\) | Chapter 3 | Latent Rules, Risk Synthesis |
| \(SD\) | Silent Deterioration score | Dimensionless | \([0, 100]\) | Chapter 9 | Composite Rules, Risk |
| \(HV\) | High Variability score | Dimensionless | \([0, 100]\) | Chapter 9 | Composite Rules, Risk |
| \(CB\) | Chronic Burden score | Dimensionless | \([0, 100]\) | Chapter 9 | Composite Rules, Risk |
| \(FR\) | False Recovery score | Dimensionless | \([0, 100]\) | Chapter 9 | Composite Rules, Risk |
| \(RD\) | Recovery Deceleration score | Dimensionless | \([0, 100]\) | Chapter 9 | Composite Rules, Risk |
| \(TC\) | Threshold Convergence score | Dimensionless | \([0, 100]\) | Chapter 9 | Composite Rules, Risk |
| \(TNR\) | Treatment Non-Responders score | Dimensionless | \([0, 100]\) | Chapter 9 | Composite Rules, Risk |
| \(SC\) | State Confidence score | Dimensionless | \([0, 100]\) | Chapter 9 | Composite Rules, Risk |
| \(Risk\) | Final risk score | Dimensionless | \([0, 100]\) | Chapter 11 | Recommendation, Validation |
| \(CI\) | Composite State Impact | Dimensionless | \([0, 50]\) | Chapter 11 | Risk Synthesis |
| \(P\) | Markov transition probability | Percentage | \([0.05, 0.90]\) | Chapter 12 | Prediction Trajectory |
| \(Utility\) | Digital Twin utility score | Dimensionless | \([0, 100]\) | Chapter 12 | Digital Twin Rankings |

*Table 3.1: Global Symbol Dictionary Matrix*

---

### CHAPTER 3: CONCLUSION

#### Key Engineering Insights
*   Standardizing mathematical symbols prevents communication errors.
*   All indices and scores are mapped to a standard `[0, 100]` range to support generalizability.
*   Every defined symbol has a specific role in ensuring clinical safety and technical consistency.

#### Design Considerations
*   TypeScript interfaces must use these terminology definitions as property and class names.
*   Documentation files must align with these terminology definitions.

#### Assumptions
*   It is assumed that target clinical guidelines are updated in compliance with medical standards.
*   It is assumed that developers are familiar with these terminology definitions.

#### Boundary Conditions
*   Each defined term is restricted to its scope; changes require formal review.
*   Terminology mappings are validated during compilation.

#### Transition to the Next Chapter
Having detailed the notation dictionary, the next chapter will present the units and dimensional analysis table.

---

## CHAPTER 4: UNITS AND DIMENSIONAL ANALYSIS

### 4.1 Dimensional Consistency Analysis
To verify the stability of the reasoning pipeline, we analyze the dimensions and units of every temporal feature and latent/composite state.

| Variable | Physical Units | Normalization Equation | Output Units | Range | Dimensionless Status | Downstream Dependencies |
| :---: | :---: | :---: | :---: | :---: | :---: | :---: |
| \(y_i\) | mg/dL | Raw value ingestion | mg/dL | \([50, 600]\) | No | VI, VOL, BDI, CBI, SCI |
| \(S\) | mg/dL/day | Regression slope | mg/dL/day | \([-5, 7.5]\) | No | Velocity Index (VI) |
| \(VI\) | mg/dL/day | \(\text{clamp}(\text{round}((S + 5) \times 8), 0, 100) \cdot 0.9\) | Dimensionless | \([0, 90]\) | Yes | SD, RD, Risk, Predictions |
| \(AI\) | mg/dL/day\(^2\) | \(\text{clamp}(\text{round}(50 + S \times 4), 0, 100) \cdot 0.88\) | Dimensionless | \([0, 88]\) | Yes | HV, Risk |
| \(VOL\) | mg/dL | \(\text{clamp}(\text{round}((RMSE / 40) \times 100), 0, 100) \cdot 0.9\) | Dimensionless | \([0, 90]\) | Yes | SD, FR, HV, TC, Risk |
| \(BDI\) | mg/dL | \(\text{clamp}(\text{round}((|\mu - 110| / 100) \times 100), 0, 100) \cdot 0.92\) | Dimensionless | \([0, 92]\) | Yes | FR, CB, TC, TNR, Risk |
| \(CBI\) | mg/dL-readings| \(\text{clamp}(\text{round}((HyperSum / (C \times 20)) \times 100), 0, 100) \cdot 0.85\)| Dimensionless | \([0, 85]\) | Yes | SD, CB, TNR, Risk |
| \(SCI\) | Readings/day | \(\text{clamp}(\text{round}(40 + Ratio \times 50 + \min(10, N)), 0, 100) \cdot 0.98\) | Dimensionless | \([0, 98]\) | Yes | SD, HE, Risk, Validation |
| \(SD\) | Dimensionless | \(\text{clamp}(CBI \cdot 0.6 + VI \cdot 0.1 + (100 - VOL) \cdot 0.3 \cdot M_{sd}, 0, 100)\) | Dimensionless | \([0, 100]\) | Yes | CC, HE, RD_comp, Risk |
| \(HV\) | Dimensionless | \(\text{clamp}(VOL \cdot 0.8 + AI \cdot 0.2, 0, 100)\) | Dimensionless | \([0, 100]\) | Yes | CC, HE, UP, EC, Risk |
| \(CB\) | Dimensionless | \(\text{clamp}(BDI \cdot 0.5 + CBI \cdot 0.5, 0, 100)\) | Dimensionless | \([0, 100]\) | Yes | CC, UP, Risk |
| \(FR\) | Dimensionless | \(\text{clamp}(VOL \cdot 0.7 + BDI \cdot 0.3, 0, 100)\) | Dimensionless | \([0, 100]\) | Yes | Risk |
| \(RD\) | Dimensionless | \(\text{clamp}(RD_{base} \cdot M_{rd}, 0, 100)\) | Dimensionless | \([0, 100]\) | Yes | Risk |
| \(TC\) | Dimensionless | \(\text{clamp}((BDI \cdot 0.4 + VOL \cdot 0.4 + M_{tc}) \cdot M_{tc\_factor}, 0, 100)\) | Dimensionless | \([0, 100]\) | Yes | Risk |
| \(TNR\) | Dimensionless | \(\text{clamp}(CB \cdot 0.6 + BDI \cdot 0.15 + M_{trend}, 40, 65)\) | Dimensionless | \([40, 65]\) | Yes | RD_comp, Risk |
| \(SC\) | Dimensionless | \(SCI\) | Dimensionless | \([0, 98]\) | Yes | Risk |
| \(Risk\)| Dimensionless | \(\text{clamp}(Risk_{calibrated} + CI \cdot 0.5, 0, 100)\) | Dimensionless | \([0, 100]\) | Yes | Recommendations, Validation|

*Table 4.1: Units and Dimensional Analysis Table*

---

### CHAPTER 4: CONCLUSION

#### Key Engineering Insights
*   Temporal metrics normalize physical units to dimensionless scales to support generalizability.
*   Risk scores weight dimensionless states, maintaining dimensional consistency.
*   Clamping constraints prevent extreme data anomalies from overflowing downstream calculations.

#### Design Considerations
*   Scaling parameters must be validated to prevent compilation errors.
*   The system must translate dimensionless indices back to physical units when displaying data to clinicians.

#### Assumptions
*   It is assumed that the target biomarker can be modeled as a time-series dataset with definable ranges.
*   It is assumed that the target baseline represents a healthy homeostatic state.

#### Boundary Conditions
*   If a calculation returns an error, the pipeline must halt and output a system error status.
*   Calculations are restricted to the selected observation window.

#### Transition to the Next Chapter
Having detailed the dimensional analysis, the next chapter will present the parameter reference table.

---

## CHAPTER 5: PARAMETER REFERENCE TABLE

### 5.1 System Calibration Constants
Table 5.1 lists the system calibration parameters, their meanings, default values, and future organ calibration guidelines.

| Parameter Name | Current Glucose Value | Current Embodiment Meaning | Future Calibration Guidelines |
| :--- | :---: | :--- | :--- |
| \(TargetBaseline\) | \(110\) mg/dL | Fasting glucose target level | Set to normal target mean for new biomarkers. |
| \(HyperThreshold\) | \(140\) mg/dL | Threshold for cumulative tissue damage | Set to onset of chronic damage boundary. |
| \(MinWindowSize\) | \(5\) days | Rolling window for trend fitting | Increase for slow-acting organ systems. |
| \(MinDataDensity\) | \(3\) readings/day | Minimum daily readings to run | Adjust based on device sampling frequencies. |
| \(VOL_{norm\_mult}\) | \(0.9\) | Volatility index normalization scale | Recalibrate if variance boundaries shift. |
| \(BDI_{norm\_mult}\) | \(0.92\) | Baseline deviation normalization scale | Recalibrate based on typical offsets. |
| \(CBI_{norm\_mult}\) | \(0.85\) | Cumulative burden normalization scale | Recalibrate based on average exposure integrals. |
| \(SCI_{norm\_mult}\) | \(0.98\) | State confidence normalization scale | Recalibrate based on target daily density. |
| \(Risk_{VOL\_weight}\)| \(0.28\) | Weight of volatility in raw risk | Increase for highly volatile conditions. |
| \(Risk_{SD\_weight}\) | \(0.26\) | Weight of silent deterioration in risk | Increase for progressive, slow organ decline. |
| \(Risk_{AI\_weight}\) | \(0.15\) | Weight of acceleration index in risk | Increase for sudden, rapid baseline shifts. |
| \(Risk_{BDI\_weight}\)| \(0.16\) | Weight of baseline deviation in risk | Increase for chronic offset priority. |
| \(Risk_{CB\_weight}\) | \(0.15\) | Weight of chronic burden in raw risk | Increase for chronic tissue damage priority. |
| \(CC_{persistence}\) | \(14\) days | Chronicity timer for Chronic Crisis | Increase for long-term chronic conditions. |
| \(EC_{persistence}\) | \(3\) days | Persistence window for Emerging Crisis | Adjust based on acute onset rates. |

*Table 5.1: Parameter Reference Table*

---

### CHAPTER 5: CONCLUSION

#### Key Engineering Insights
*   Calibration parameters define target limits, window sizes, and state gating thresholds.
*   Configurable thresholds allow the engine to be calibrated for different biomarkers without code changes.
*   Weights are allocated to balance acute volatility and chronic baseline drift risks.

#### Design Considerations
*   Configuration files must be validated for range limits to prevent invalid thresholds from causing mathematical errors.
*   The system must expose the active configuration in the metadata sheet to support auditability.

#### Assumptions
*   It is assumed that the calibration parameters reflect target clinical safety guidelines.
*   It is assumed that parameters are read-only during active monitoring sessions.

#### Boundary Conditions
*   Changes to parameters require regression testing across all 10 clinical profiles.
*   The system specification is restricted to the current system version (2.1.0).

#### Transition to the Next Chapter
Having detailed the calibration parameters, the next chapter will define the telemetry mathematical model.

---

## CHAPTER 6: TELEMETRY MATHEMATICAL MODEL

### 6.1 Spacing Time Delta and Densities
Let the discrete telemetry dataset be represented as a finite set of chronological measurements:
\[M = \{(t_i, y_i) \mid i \in [0, N-1],\, t_i \in \mathbb{R}^+,\, y_i \in \mathbb{R}^+\}\]
We define the time difference delta between consecutive measurements as:
\[\Delta t_i = t_i - t_{i-1},\quad i \in [1, N-1]\quad \text{Equation (6.1)}\]

The observation span \(D\) of the telemetry set \(M\) in days is computed as:
\[D = \frac{t_{N-1} - t_0}{86400}\quad \text{Equation (6.2)}\]

We define the average sampling density \(\rho\) (readings per day) as:
\[\rho = \frac{N}{\max(D, 1.0)}\quad \text{Equation (6.3)}\]

---

### CHAPTER 6: CONCLUSION

#### Key Engineering Insights
*   Telemetry measurements are non-uniformly spaced, requiring time-difference scaling.
*   Average sampling density (\(\rho\)) is a key indicator of data quality and completeness.
*   The observation span (\(D\)) must be computed in standard units (days).

#### Design Considerations
*   The ingestion layer must filter out duplicate entries (identical timestamps).
*   All time calculations must handle timezone offsets consistently.

#### Assumptions
*   It is assumed that the timestamps are represented in standard Unix epoch seconds.
*   It is assumed that the telemetry data density is sufficient to construct trend lines.

#### Boundary Conditions
*   If the observation span \(D \le 0\), the density \(\rho\) is set to \(N\).
*   Individual telemetry inputs are clamped to defined boundaries.

#### Transition to the Next Chapter
Having defined the telemetry model, the next chapter will formulate the six primary temporal metrics.

---

## CHAPTER 7: TEMPORAL METRIC FORMULATION

### 7.1 Velocity Index (VI)
*   **Engineering Motivation:** Quantifying the rate of change of the physiological baseline.
*   **Equation:**
    \[S = \frac{\sum_{d=1}^K (d - \bar{d})(\bar{y}_d - \bar{y})}{\sum_{d=1}^K (d - \bar{d})^2}\quad \text{Equation (7.1)}\]
    \[VI_{raw} = \text{clamp}(\text{round}((S + 5) \times 8), 0, 100)\quad \text{Equation (7.2)}\]
    \[VI_{norm} = \text{round}(VI_{raw} \times 0.9)\quad \text{Equation (7.3)}\]
    where \(S\) is the slope of linear regression over daily averages \(\bar{y}_d\), \(K\) is the regression window, and \(\bar{d}\) is the mean day index.
*   **Units:** mg/dL per day (in the current glucose embodiment).
*   **Constraints:** \(K \ge 3\) days of data are required.
*   **Boundary Conditions:** Clamped to the range \([0, 100]\).
*   **Interpretation:** A positive slope indicates a creeping upward trend; a negative slope indicates a downward trend.
*   **Failure Modes:** Sparse data (fewer than 3 days) causes regression instability.
*   **Numerical Example:** Given slope \(S = 5\):
    \[VI_{raw} = \text{clamp}(\text{round}((5 + 5) \times 8), 0, 100) = 80\]
    \[VI_{norm} = \text{round}(80 \times 0.9) = 72\]
*   **Relationship to Downstream Calculations:** Drives *Silent Deterioration* and *Recovery Deceleration* latent states.

---

### 7.2 Acceleration Index (AI)
*   **Engineering Motivation:** Quantifying changes in baseline velocity.
*   **Equation:**
    \[AI_{raw} = \text{clamp}(\text{round}(50 + S \times 4), 0, 100)\quad \text{Equation (7.4)}\]
    \[AI_{norm} = \text{round}(AI_{raw} \times 0.88)\quad \text{Equation (7.5)}\]
    where \(S\) is the slope of linear regression over daily averages.
*   **Units:** mg/dL per day\(^2\) (in the current glucose embodiment).
*   **Constraints:** Requires at least two consecutive regression windows.
*   **Boundary Conditions:** Clamped to the range \([0, 100]\).
*   **Interpretation:** Values \(> 50\) indicate accelerating trends; values \(< 50\) indicate decelerating trends.
*   **Failure Modes:** High noise in daily averages can inflate acceleration indices.
*   **Numerical Example:** Given slope \(S = 3\):
    \[AI_{raw} = \text{clamp}(\text{round}(50 + 3 \times 4), 0, 100) = 62\]
    \[AI_{norm} = \text{round}(62 \times 0.88) = 55\]
*   **Relationship to Downstream Calculations:** Drives the *High Variability* latent state.

---

### 7.3 Volatility Index (VOL)
*   **Engineering Motivation:** Measuring homeostatic instability independent of overall baseline trends.
*   **Equation:**
    \[RMSE = \sqrt{\frac{1}{N}\sum_{i=0}^{N-1} (y_i - \hat{y}_i)^2}\quad \text{Equation (7.6)}\]
    \[VOL_{raw} = \text{clamp}\left(\text{round}\left(\frac{RMSE}{40} \times 100\right), 0, 100\right)\quad \text{Equation (7.7)}\]
    \[VOL_{norm} = \text{round}(VOL_{raw} \times 0.9)\quad \text{Equation (7.8)}\]
    where \(RMSE\) is the standard deviation of residuals, and \(\hat{y}_i\) is the regression trend line prediction.
*   **Units:** mg/dL.
*   **Constraints:** \(N \ge 5\) measurements are required.
*   **Boundary Conditions:** Clamped to the range \([0, 100]\).
*   **Interpretation:** High values indicate regulatory instability and volatility; low values indicate stable baseline control.
*   **Failure Modes:** Outliers in telemetry can inflate the RMSE calculation.
*   **Numerical Example:** Given \(RMSE = 10\):
    \[VOL_{raw} = \text{clamp}\left(\text{round}\left(\frac{10}{40} \times 100\right), 0, 100\right) = 25\]
    \[VOL_{norm} = \text{round}(25 \times 0.9) = 23\]
*   **Relationship to Downstream Calculations:** Drives *Silent Deterioration*, *False Recovery*, and *High Variability* latent states.

---

### 7.4 Baseline Deviation Index (BDI)
*   **Engineering Motivation:** Quantifying the patient's distance from target physiological baseline levels.
*   **Equation:**
    \[BDI_{raw} = \text{clamp}\left(\text{round}\left(\frac{|\mu - T|}{100} \times 100\right), 0, 100\right)\quad \text{Equation (7.9)}\]
    \[BDI_{norm} = \text{round}(BDI_{raw} \times 0.92)\quad \text{Equation (7.10)}\]
    where \(\mu\) is the average biomarker value, and \(T = 110\) mg/dL is the target baseline.
*   **Units:** mg/dL.
*   **Constraints:** Requires at least 5 days of data.
*   **Boundary Conditions:** Clamped to the range \([0, 100]\).
*   **Interpretation:** Higher values represent greater deviation from target baseline levels.
*   **Failure Modes:** Systemic sensor calibration offset can distort the BDI calculation.
*   **Numerical Example:** Given \(\mu = 145\):
    \[BDI_{raw} = \text{clamp}\left(\text{round}\left(\frac{|145 - 110|}{100} \times 100\right), 0, 100\right) = 35\]
    \[BDI_{norm} = \text{round}(35 \times 0.92) = 32\]
*   **Relationship to Downstream Calculations:** Drives *Chronic Burden*, *False Recovery*, and *Threshold Convergence* latent states.

---

### 7.5 Cumulative Burden Index (CBI)
*   **Engineering Motivation:** Quantifying cumulative exposure to abnormal biomarker levels.
*   **Equation:**
    \[HyperSum = \sum_{y_i > 140} (y_i - 140)\quad \text{Equation (7.11)}\]
    \[CBI_{raw} = \text{clamp}\left(\text{round}\left(\frac{HyperSum}{N \times 20} \times 100\right), 0, 100\right)\quad \text{Equation (7.12)}\]
    \[CBI_{norm} = \text{round}(CBI_{raw} \times 0.85)\quad \text{Equation (7.13)}\]
    where \(HyperSum\) integrates values exceeding the threshold of \(140\) mg/dL.
*   **Units:** mg/dL-readings.
*   **Constraints:** Requires at least 5 measurements.
*   **Boundary Conditions:** Clamped to the range \([0, 100]\).
*   **Interpretation:** High values indicate sustained, chronic hyperglycemic exposure.
*   **Failure Modes:** Sparse data can underestimate cumulative exposure.
*   **Numerical Example:** Given \(HyperSum = 400\) over \(N = 20\) readings:
    \[CBI_{raw} = \text{clamp}\left(\text{round}\left(\frac{400}{20 \times 20} \times 100\right), 0, 100\right) = 100\]
    \[CBI_{norm} = \text{round}(100 \times 0.85) = 85\]
*   **Relationship to Downstream Calculations:** Drives *Silent Deterioration* and *Chronic Burden* latent states.

---

### 7.6 State Confidence Index (SCI)
*   **Engineering Motivation:** Evaluating telemetry data density and completeness.
*   **Equation:**
    \[Ratio = \text{clamp}\left(\frac{N}{D \times 3}, 0, 1.2\right)\quad \text{Equation (7.14)}\]
    \[SCI_{raw} = \text{clamp}(\text{round}(40 + Ratio \times 50 + \min(10, N)), 0, 100)\quad \text{Equation (7.15)}\]
    \[SCI_{norm} = \text{round}(SCI_{raw} \times 0.98)\quad \text{Equation (7.16)}\]
    where \(Ratio\) compares measurements to target daily readings over observation span \(D\).
*   **Units:** Dimensionless ratio.
*   **Constraints:** \(D > 0\).
*   **Boundary Conditions:** Clamped to the range \([0, 100]\).
*   **Interpretation:** Higher values represent greater data completeness and confidence.
*   **Failure Modes:** Short monitoring windows (e.g. \(D < 2\) days) can artificially inflate confidence scores.
*   **Numerical Example:** Given \(N = 30\) readings over \(D = 10\) days:
    \[Ratio = \text{clamp}\left(\frac{30}{10 \times 3}, 0, 1.2\right) = 1.0\]
    \[SCI_{raw} = \text{clamp}(\text{round}(40 + 1.0 \times 50 + \min(10, 30)), 0, 100) = 100\]
    \[SCI_{norm} = \text{round}(100 \times 0.98) = 98\]
*   **Relationship to Downstream Calculations:** Calibrates risk scores and latent state eligibility.

---

### CHAPTER 7: CONCLUSION

#### Key Engineering Insights
*   Each temporal metric measures a distinct property of the homeostatic feedback system.
*   Mathematical formulas utilize rolling windows and normalization to filter noise and standardize outputs.
*   Confidence indexing (SCI) prevents data sparsity from triggering false-positive alerts.

#### Design Considerations
*   Clamping parameters must be verified to prevent mathematical overflow.
*   The baseline target must be configurable to support personalization.

#### Assumptions
*   It is assumed that the sampling interval is consistent enough to allow calculation of derivatives.
*   It is assumed that the target baseline represents a healthy homeostatic state.

#### Boundary Conditions
*   If data density is insufficient, the system flags the metrics as low-confidence.
*   Outliers are clamped during calculation to prevent mathematical distortion.

#### Transition to the Next Chapter
Having formulated the temporal metrics, the next chapter will define the normalization and scaling theory.

---

## CHAPTER 8: NORMALIZATION AND SCALING THEORY

### 8.1 Clamping and Range Adjustments
The normalization process maps raw indices \(I_{raw}\) to standard scales. This transformation is defined as:
\[I_{norm} = \text{round}(I_{raw} \times \lambda_{scale})\quad \text{Equation (8.1)}\]
where:
*   \(\lambda_{scale}\) is the scaling constant (e.g. \(0.9\) for Volatility, \(0.92\) for BDI).
*   Clamping functions enforce limits:
    \[\text{clamp}(x, L, U) = \max(L, \min(x, U))\quad \text{Equation (8.2)}\]

By rounding results and clamping outputs to defined boundaries, the engine prevents calculation overflows while maintaining type consistency.

---

### CHAPTER 8: CONCLUSION

#### Key Engineering Insights
*   Standardizing clinical indices on a `[0, 100]` scale enables a biomarker-agnostic architecture.
*   Mapping functions utilize scaling multipliers and translation offsets.
*   Clamping prevents extreme data anomalies from overflowing downstream calculations.

#### Design Considerations
*   Scaling parameters must be calibrated for each biomarker to ensure correct risk mapping.
*   The user interface must translate dimensionless indices back to physical units.

#### Assumptions
*   It is assumed that the target biomarker can be modeled as a time-series dataset with definable ranges.
*   It is assumed that the target baseline represents a healthy homeostatic state.

#### Boundary Conditions
*   If a metric calculation returns an error, the pipeline must halt and output a system error status.
*   Calculations are restricted to the selected observation window.

#### Transition to the Next Chapter
Having detailed the normalization theory, the next chapter will formulate the latent state gating equations.

---

## CHAPTER 9: LATENT STATE MATHEMATICAL FORMULATION

### 9.1 Gating Rules and Score Weightings
The TCRE evaluates eight latent clinical states. If eligibility gates are met, the state score is computed as a weighted sum of temporal indices.

#### 9.1.1 Silent Deterioration (SD)
*   **Eligibility Gates:**
    \[Gate_{eligibility} = (Slope\ trend\ is\ \text{'up'}\ \lor\ VI_{raw} > 40) \land (SCI_{raw} > 60) \land (D \ge 5)\quad \text{Equation (9.1)}\]
*   **Equation:**
    \[SD_{score} = \text{clamp}(CBI_{raw} \cdot 0.6 + VI_{raw} \cdot 0.1 + (100 - VOL_{raw}) \cdot 0.3 \cdot M_{sd},\, 0,\, 100)\quad \text{Equation (9.2)}\]
    where \(M_{sd}\) is the slope multiplier.
*   **Units:** Dimensionless score.
*   **Constraints:** \(D \ge 5\) days.
*   **Boundary Conditions:** Clamped to \([0, 100]\).
*   **Interpretation:** Tracks progressive baseline deterioration.
*   **Failure Modes:** High volatility can disable the gate.
*   **Numerical Example:** Given \(CBI_{raw} = 50\), \(VI_{raw} = 60\), \(VOL_{raw} = 20\), and \(M_{sd} = 1.0\):
    \[SD_{score} = \text{clamp}(50 \cdot 0.6 + 60 \cdot 0.1 + (100 - 20) \cdot 0.3 \cdot 1.0,\, 0,\, 100) = 60\]
*   **Relationship to Downstream Calculations:** Drives *Emerging Crisis* and *Chronic Crisis* composite states.

---

#### 9.1.2 False Recovery (FR)
*   **Eligibility Gates:**
    \[Gate_{eligibility} = (Drop > 15) \land (VOL_{raw} > 28)\quad \text{Equation (9.3)}\]
*   **Equation:**
    \[FR_{score} = \text{clamp}(VOL_{raw} \cdot 0.7 + BDI_{raw} \cdot 0.3,\, 0,\, 100)\quad \text{Equation (9.4)}\]
*   **Units:** Dimensionless score.
*   **Boundary Conditions:** Clamped to \([0, 100]\).
*   **Interpretation:** Tracks risk of premature treatment de-escalation.
*   **Failure Modes:** Slow recovery profiles may not trigger the gate.
*   **Numerical Example:** Given \(VOL_{raw} = 40\) and \(BDI_{raw} = 30\):
    \[FR_{score} = \text{clamp}(40 \cdot 0.7 + 30 \cdot 0.3,\, 0,\, 100) = 37\]
*   **Relationship to Downstream Calculations:** Prioritizes caution recommendations.

---

#### 9.1.3 Chronic Burden (CB)
*   **Eligibility Gates:**
    \[Gate_{eligibility} = (\mu > 130) \land (D \ge 5)\quad \text{Equation (9.5)}\]
*   **Equation:**
    \[CB_{score} = \text{clamp}(BDI_{raw} \cdot 0.5 + CBI_{raw} \cdot 0.5,\, 0,\, 100)\quad \text{Equation (9.6)}\]
*   **Units:** Dimensionless score.
*   **Boundary Conditions:** Clamped to \([0, 100]\).
*   **Interpretation:** Tracks chronic baseline offset.
*   **Failure Modes:** Shorter windows can distort the average.
*   **Numerical Example:** Given \(BDI_{raw} = 40\) and \(CBI_{raw} = 60\):
    \[CB_{score} = \text{clamp}(40 \cdot 0.5 + 60 \cdot 0.5,\, 0,\, 100) = 50\]
*   **Relationship to Downstream Calculations:** Drives *Chronic Crisis* and *Unstable Plateau* composite states.

---

#### 9.1.4 High Variability (HV)
*   **Eligibility Gates:**
    \[Gate_{eligibility} = VOL_{raw} > 25\quad \text{Equation (9.7)}\]
*   **Equation:**
    \[HV_{score} = \text{clamp}(VOL_{raw} \cdot 0.8 + AI_{raw} \cdot 0.2,\, 0,\, 100)\quad \text{Equation (9.8)}\]
*   **Units:** Dimensionless score.
*   **Boundary Conditions:** Clamped to \([0, 100]\).
*   **Interpretation:** Tracks regulatory instability and fluctuations.
*   **Failure Modes:** Single outliers can inflate the score.
*   **Numerical Example:** Given \(VOL_{raw} = 50\) and \(AI_{raw} = 60\):
    \[HV_{score} = \text{clamp}(50 \cdot 0.8 + 60 \cdot 0.2,\, 0,\, 100) = 52\]
*   **Relationship to Downstream Calculations:** Drives *Emerging Crisis* and *Unstable Plateau* composite states.

---

#### 9.1.5 Recovery Deceleration (RD)
*   **Eligibility Gates:**
    \[Gate_{eligibility} = (Slope < -0.8) \land (VI_{raw} < 45)\quad \text{Equation (9.9)}\]
*   **Equation:**
    \[RD_{score} = \text{clamp}(RD_{base} \cdot M_{rd},\, 0,\, 100)\quad \text{Equation (9.10)}\]
    where \(M_{rd}\) is the recovery multiplier.
*   **Units:** Dimensionless score.
*   **Boundary Conditions:** Clamped to \([0, 100]\).
*   **Interpretation:** Tracks stabilization phases.
*   **Failure Modes:** Slow deceleration trends can go undetected.
*   **Numerical Example:** Given \(RD_{base} = 40\) and \(M_{rd} = 1.1\):
    \[RD_{score} = \text{clamp}(40 \cdot 1.1,\, 0,\, 100) = 44\]
*   **Relationship to Downstream Calculations:** Prioritizes maintenance recommendations.

---

#### 9.1.6 Threshold Convergence (TC)
*   **Eligibility Gates:**
    \[Gate_{eligibility} = |BDI_{raw} - VOL_{raw}| < 10\quad \text{Equation (9.11)}\]
*   **Equation:**
    \[TC_{score} = \text{clamp}((BDI_{raw} \cdot 0.4 + VOL_{raw} \cdot 0.4 + M_{tc}) \cdot M_{tc\_factor},\, 0,\, 100)\quad \text{Equation (9.12)}\]
    where \(M_{tc}\) is the convergence offset.
*   **Units:** Dimensionless score.
*   **Boundary Conditions:** Clamped to \([0, 100]\).
*   **Interpretation:** Tracks coupled metric convergence.
*   **Failure Modes:** Rapid baseline fluctuations can break convergence.
*   **Numerical Example:** Given \(BDI_{raw} = 30\) and \(VOL_{raw} = 32\):
    \[TC_{score} = \text{clamp}((30 \cdot 0.4 + 32 \cdot 0.4 + 5) \cdot 1.0,\, 0,\, 100) = 30\]
*   **Relationship to Downstream Calculations:** Prioritizes stability recommendations.

---

#### 9.1.7 Treatment Non-Responders (TNR)
*   **Eligibility Gates:**
    \[Gate_{eligibility} = (Intervention = \text{True}) \land (CB_{score} > 40) \land (Slope \ge -0.2)\quad \text{Equation (9.13)}\]
*   **Equation:**
    \[TNR_{score} = \text{clamp}(CB_{score} \cdot 0.6 + BDI_{raw} \cdot 0.15 + M_{trend},\, 40,\, 65)\quad \text{Equation (9.14)}\]
    where \(M_{trend}\) is the slope modifier.
*   **Units:** Dimensionless score.
*   **Boundary Conditions:** Clamped to the range \([40, 65]\).
*   **Interpretation:** Tracks resistance to therapy.
*   **Failure Modes:** Incomplete intervention logs can disable the gate.
*   **Numerical Example:** Given \(CB_{score} = 50\), \(BDI_{raw} = 40\), and \(M_{trend} = 5\):
    \[TNR_{score} = \text{clamp}(50 \cdot 0.6 + 40 \cdot 0.15 + 5,\, 40,\, 65) = 41\]
*   **Relationship to Downstream Calculations:** Prioritizes specialist consultation overrides.

---

#### 9.1.8 State Confidence (SC)
*   **Eligibility Gates:**
    \[Gate_{eligibility} = SCI_{raw} > 0\quad \text{Equation (9.15)}\]
*   **Equation:**
    \[SC_{score} = SCI_{raw}\quad \text{Equation (9.16)}\]
*   **Units:** Dimensionless score.
*   **Boundary Conditions:** Clamped to \([0, 100]\).
*   **Interpretation:** Tracks data quality.
*   **Failure Modes:** Short windows can distort the score.
*   **Numerical Example:** Given \(SCI_{raw} = 90\):
    \[SC_{score} = 90\]
*   **Relationship to Downstream Calculations:** Calibrates final risk scores.

---

### CHAPTER 9: CONCLUSION

#### Key Engineering Insights
*   Latent clinical states are evaluated using Boolean logic gates and weighted sum equations.
*   Deterministic score calculations replace probabilistic inference.
*   Confidence indexing (SC) prevents data sparsity from triggering false-positive alerts.

#### Design Considerations
*   Boolean gates must be audited for conflict conditions to prevent contradictory state classifications.
*   Gating thresholds must be configurable parameters to allow personalization.

#### Assumptions
*   It is assumed that the inputs represent measurements taken under consistent physiological conditions.
*   It is assumed that the target baseline represents a healthy homeostatic state.

#### Boundary Conditions
*   If a calculation returns an error, the pipeline must halt and output a system error status.
*   Calculations are restricted to the selected observation window.

#### Transition to the Next Chapter
Having formulated the latent states, the next chapter will define the composite state gating equations.

---

## CHAPTER 10: COMPOSITE STATE MATHEMATICAL FORMULATION

### 10.1 Interaction Rules and Chronicity Gates
Composite states evaluate interactions between multiple active latent profiles. Rules are detailed in the following sections.

#### 10.1.1 Chronic Crisis (CC)
*   **Gating Rules:**
    \[CC_{status} = \text{'Active'}\quad \text{if}\quad (CB_{score} > 50) \land (SD_{score} > 40) \land (HV_{score} > 40) \land (D \ge 14) \land (VI_{raw} > 45)\quad \text{Equation (10.1)}\]
*   **Score Equation:**
    If \(CC_{status} = \text{'Active'}\):
    \[CC_{score} = \text{clamp}(CB_{score} \cdot 0.4 + SD_{score} \cdot 0.3 + HV_{score} \cdot 0.3,\, 0,\, 100)\quad \text{Equation (10.2)}\]

---

#### 10.1.2 Hidden Escalation (HE)
*   **Gating Rules:**
    \[HE_{status} = \text{'Active'}\quad \text{if}\quad (SD_{score} > 45) \land (SCI_{raw} > 65) \land (HV_{score} < 32) \land (VI_{raw} \ge 48) \land (AI_{raw} \in [40, 65])\quad \text{Equation (10.3)}\]
*   **Score Equation:**
    If \(HE_{status} = \text{'Active'}\):
    \[HE_{score} = \text{clamp}(SD_{score} \cdot 0.7 + (100 - HV_{score}) \cdot 0.3,\, 0,\, 100)\quad \text{Equation (10.4)}\]

---

#### 10.1.3 Refractory Deterioration (RD_comp)
*   **Gating Rules:**
    \[RD\_comp_{status} = \text{'Active'}\quad \text{if}\quad (SD_{score} > 40) \land (TNR_{score} > 40) \land (Slope > 0.1) \land (HV_{score} < 45)\quad \text{Equation (10.5)}\]
*   **Score Equation:**
    If \(RD\_comp_{status} = \text{'Active'}\):
    \[RD\_comp_{score} = \text{clamp}(SD_{score} \cdot 0.5 + TNR_{score} \cdot 0.5,\, 0,\, 100)\quad \text{Equation (10.6)}\]

---

#### 10.1.4 Unstable Plateau (UP)
*   **Gating Rules:**
    \[UP_{status} = \text{'Active'}\quad \text{if}\quad (CB_{score} > 50) \land (HV_{score} > 50) \land (|Slope| < 1.0)\quad \text{Equation (10.7)}\]
*   **Score Equation:**
    If \(UP_{status} = \text{'Active'}\):
    \[UP_{score} = \text{clamp}(CB_{score} \cdot 0.5 + HV_{score} \cdot 0.5,\, 0,\, 100)\quad \text{Equation (10.8)}\]

---

#### 10.1.5 Emerging Crisis (EC)
*   **Gating Rules:**
    Constituent States Met: \(SD_{score} \ge 35\) and \(HV_{score} \ge 35\).
    *   **Active:** Persistence days \(\ge 3.0\) and Interaction strength \(\ge 0.50\).
    *   **Candidate:** Persistence days \(< 3.0\) or Interaction strength \(< 0.50\).
    *   **Emerging:** Only one latent state active.
    *   **Inactive:** Neither state active.
*   **Score Equation:**
    If \(EC_{status} = \text{'Active'}\):
    \[EC_{score} = \text{clamp}(SD_{score} \cdot 0.5 + HV_{score} \cdot 0.5,\, 0,\, 100)\quad \text{Equation (10.9)}\]

---

### CHAPTER 10: CONCLUSION

#### Key Engineering Insights
*   Composite states model high-order physiological interactions, identifying complex risk patterns.
*   Boolean gating rules evaluate constituent latent state scores, persistence days, and trends.
*   Status levels (Active, Candidate, Emerging, Inactive) categorize clinical urgency.

#### Design Considerations
*   Persistence timers must handle missing data points without resetting the day count.
*   Gating rules must avoid circular dependencies to prevent infinite loops.

#### Assumptions
*   It is assumed that the clinician is the final decision-maker, using recommendations as advisory inputs.
*   It is assumed that the patient's physiology conforms to general homeostatic principles.

#### Boundary Conditions
*   If data density is insufficient, the system flags the metrics as low-confidence.
*   Risk amplification is restricted to active composite states.

#### Transition to the Next Chapter
Having formulated the composite states, the next chapter will define the risk synthesis and recommendation prioritization equations.

---

## CHAPTER 11: RISK SYNTHESIS & RECOMMENDATION PRIORITIZATION MATHEMATICS

### 11.1 The Complete Risk Equation
The metabolic risk score \(Risk_{final}\) is computed using the following equation:
\[Risk_{raw} = \text{clamp}(\text{round}(V \cdot 0.28 + SD \cdot 0.26 + AI \cdot 0.15 + B \cdot 0.16 + CB \cdot 0.15),\, 0,\, 100)\quad \text{Equation (11.1)}\]
\[Risk_{calibrated} = \text{clamp}\left(\text{round}\left(Risk_{raw} \cdot \left(0.9 + \frac{SCI_{raw}}{1000}\right)\right),\, 0,\, 100\right)\quad \text{Equation (11.2)}\]
\[Risk_{final} = \text{clamp}\left(Risk_{calibrated} + \text{round}(CI \cdot 0.5),\, 0,\, 100\right)\quad \text{Equation (11.3)}\]
where:
*   \(V = VOL_{raw}\)
*   \(SD = SD_{score}\)
*   \(AI = AI_{raw}\)
*   \(B = BDI_{raw}\)
*   \(CB = CB_{score}\)
*   \(CI = \text{CompositeScore} \cdot \frac{\text{CompositeConfidence}}{100}\) for active composite states.

### 11.2 Prioritization Indices
Actionable clinician guidelines are selected dynamically based on active composite states, latent states, and risk tiers. Selected recommendations are categorized into:

*   **URGENT:** Added if \(Risk_{final} \ge 76\).
*   **PRIMARY:** Direct interventions targeted at active composite states.
*   **SECONDARY:** Secondary checks and monitoring adjustments.
*   **SUPPORTING:** Diagnostic assays and routine evaluations.

Priority within each category is determined by the confidence level of the triggering state.

---

### CHAPTER 11: CONCLUSION

#### Key Engineering Insights
*   The risk score combines volatility, baseline deviation, and latent/composite states.
*   Data completeness (SCI) adjusts the risk score to prevent false alarms in sparse datasets.
*   Active composite crisis states amplify the final risk score to reflect clinical urgency.

#### Design Considerations
*   Weight parameters must sum to \(1.0\) to keep the raw risk score within the `[0, 100]` range.
*   Amplifier caps must be configured to prevent the final score from overflowing.

#### Assumptions
*   It is assumed that the selected weights reflect clinical risk priorities.
*   It is assumed that the patient's physiology conforms to general homeostatic principles.

#### Boundary Conditions
*   If the risk score crosses defined limits (e.g. \(Risk_{final} \ge 76\)), the system triggers critical overrides.
*   Risk calculations are restricted to the selected observation window.

#### Transition to the Next Chapter
Having detailed the risk synthesis, the next chapter will define the prediction and Digital Twin simulation equations.

---

## CHAPTER 12: PREDICTION, TRAJECTORY, AND DIGITAL TWIN MATHEMATICS

### 12.1 Markov Transition Probability Allocation
To project future trajectories, the TCRE defines a three-state discrete Markov chain representing the transition pathways: Decline (\(State_D\)), Maintenance (\(State_M\)), and Recovery (\(State_R\)).

Let the transition probability vector at time \(t\) be represented as:
\[\mathbf{P}(t) = [P_D(t),\, P_M(t),\, P_R(t)]\quad \text{Equation (12.1)}\]
where:
\[P_D(t) + P_M(t) + P_R(t) = 1.0\quad \text{Equation (12.2)}\]

These probabilities are allocated based on Volatility (\(VOL_{raw}\)) and Baseline Deviation (\(BDI_{raw}\)) indices:
\[P_D(t) = \text{clamp}\left(\frac{VOL_{raw} \cdot 0.6 + BDI_{raw} \cdot 0.4}{100},\, 0.05,\, 0.90\right)\quad \text{Equation (12.3)}\]
\[P_R(t) = \text{clamp}\left((1.0 - P_D(t)) \cdot \left(1.0 - \frac{BDI_{raw}}{100}\right),\, 0.05,\, 0.90\right)\quad \text{Equation (12.4)}\]
\[P_M(t) = 1.0 - P_D(t) - P_R(t)\quad \text{Equation (12.5)}\]

### 12.2 Digital Twin Utility Scores
The Digital Twin Simulator models patient parameters under four hypothetical intervention scenarios, applying multipliers to baseline indices:

*   **Scenario A (Current Treatment):** Modifiers = \(1.0\) (Baseline remains unchanged).
*   **Scenario B (Increase Monitoring):** \(SCI_{raw} = \min(SCI_{raw} + 15,\, 100)\).
*   **Scenario C (Reduce Volatility):** \(VOL_{raw} = VOL_{raw} \times 0.8\).
*   **Scenario D (Reduce Deviation):** \(BDI_{raw} = BDI_{raw} \times 0.85\); \(CBI_{raw} = CBI_{raw} \times 0.90\).

For each scenario, the engine recalculates latent states, composite states, and risk scores. The efficacy of each scenario is ranked using a weighted utility score:
\[Utility = \text{round}(R \cdot 0.35 + C \cdot 0.15 + T \cdot 0.20 + S \cdot 0.15 + P \cdot 0.15)\quad \text{Equation (12.6)}\]
where:
*   \(R\) is the Risk Reduction: \(R = Risk_{baseline} - Risk_{simulated}\).
*   \(C\) is the Diagnostic Confidence: \(C = SCI_{simulated}\).
*   \(T\) is the Trajectory Improvement: \(T = P_{R, simulated} \times 100\).
*   \(S\) is the Intervention Time Saved.
*   \(P\) is the Pancreatic Reserve Preservation.

Scenarios are ranked in descending order of utility score (excluding Scenario A).

---

### CHAPTER 12: CONCLUSION

#### Key Engineering Insights
*   Markov transition probabilities model future physiological pathways (Decline, Maintenance, Recovery).
*   Probabilities are allocated based on volatility and baseline deviation.
*   The transition vector sums to \(1.0\), keeping predictions within probability bounds.

#### Design Considerations
*   Clamp parameters must be configured to prevent probabilities from reaching \(0\) or \(1\), representing absolute certainty.
*   The transition matrix must update dynamically as indices change.

#### Assumptions
*   It is assumed that future trends can be modeled as a discrete Markov process.
*   It is assumed that the patient's physiology conforms to general homeostatic principles.

#### Boundary Conditions
*   Transition projections are restricted to the selected prediction window (e.g. 30 days).
*   Predictions ignore external variables not captured in raw telemetry.

#### Transition to the Next Chapter
Having detailed the prediction mathematics, the next chapter will outline the mathematical invariants and numerical stability constraints.

---

## CHAPTER 13: MATHEMATICAL INVARIANTS & NUMERICAL STABILITY

### 13.1 Pipeline Invariant Properties
To verify the stability of the reasoning pipeline, we define a set of mathematical invariants that must remain true for all telemetry inputs:

1.  **State Confidence Bounds:** The State Confidence Index must lie within the range:
    \[SCI \in [0, 100]\quad \text{Equation (13.1)}\]
2.  **Risk Score Bounds:** The final risk score must lie within the range:
    \[Risk_{final} \in [0, 100]\quad \text{Equation (13.2)}\]
3.  **Latent State Score Bounds:** The calculated latent state scores must lie within the range:
    \[StateScore_k \in [0, 100]\quad \text{Equation (13.3)}\]
4.  **Composite State Score Bounds:** The calculated composite state scores must lie within the range:
    \[CompositeScore_m \in [0, 100]\quad \text{Equation (13.4)}\]
5.  **Markov Probability Bounds:** The allocated Markov pathway probabilities must sum to \(1.0\):
    \[P_D(t) + P_M(t) + P_R(t) = 1.0\quad \text{Equation (13.5)}\]
6.  **Non-Negative Confidence:** Confidence and SCI values must never be negative.
7.  **Minimum Window Constraint:** Regression windows must contain at least three daily averages:
    \[K \ge 3\quad \text{Equation (13.6)}\]
8.  **Minimum Sampling Density:** Calculations are flagged as low confidence if the sampling density drops below the minimum threshold:
    \[\rho < 3\text{ readings/day}\quad \text{Equation (13.7)}\]

---

### 13.2 Numerical Analysis Metrics
The TCRE calculation core implements several safeguards to maintain numerical stability during execution:

*   **Floating-Point Safeguards:** All division calculations use safe division utilities (e.g. checks for zero denominators) to prevent runtime crashes.
*   **Rounding and Clamping:** Calculations are rounded to the nearest integer and clamped to defined boundaries (e.g. `[0, 100]`) to prevent mathematical overflow.
*   **Handling Epsilon Values:** All comparisons use epsilon values to prevent rounding errors:
    \[\epsilon = 10^{-7}\quad \text{Equation (13.8)}\]
*   **Handling Missing Values:** Missing values are handled by skipping the invalid record, preventing mathematical distortion of downstream calculations.
*   **Handling Duplicate Timestamps:** Duplicate measurements (identical timestamps) are filtered out before calculations begin.
*   **Outlier Clamping:** Extreme outliers are clamped to defined boundaries (e.g. 50 to 600 mg/dL for blood glucose) to prevent mathematical distortion.

---

### CHAPTER 13: CONCLUSION

#### Key Engineering Insights
*   Mathematical invariants define safety boundaries that must remain true for all inputs.
*   Clamping and safe division utilities maintain numerical stability, preventing runtime crashes.
*   Outlier clamping and duplicate filtering prevent mathematical distortion of downstream metrics.

#### Design Considerations
*   TypeScript implementations must enforce these invariant checks during execution.
*   Validation test suites must include edge-case datasets to verify numerical stability.

#### Assumptions
*   It is assumed that the client browser runtime provides adequate memory and processing capacity.
*   It is assumed that the incoming telemetry stream represents a single patient's longitudinal physiological markers.

#### Boundary Conditions
*   If an invariant is violated, the system release flag is set to blocked.
*   Validation audits are restricted to the active session state.

#### Transition to the Next Chapter
Having detailed the invariants, the next chapter will present the computational complexity analysis.

---

## CHAPTER 14: COMPUTATIONAL COMPLEXITY

### 14.1 Algorithmic Complexity Bounds
Table 14.1 lists the computational complexity (Time and Memory) for every major algorithm in the TCRE pipeline.

| Algorithm Name | Time Complexity (Best Case) | Time Complexity (Worst Case) | Memory Complexity | Window Size (\(N\)) | Maximum Input Size (\(N_{max}\)) |
| :--- | :---: | :---: | :---: | :---: | :---: |
| **Telemetry Ingestion** | \(\mathcal{O}(N)\) | \(\mathcal{O}(N \log N)\) | \(\mathcal{O}(N)\) | All | \(10,000\) readings |
| **Linear Regression** | \(\mathcal{O}(K)\) | \(\mathcal{O}(K)\) | \(\mathcal{O}(1)\) | \(5\) days | \(90\) days |
| **Volatility (RMSE)** | \(\mathcal{O}(N)\) | \(\mathcal{O}(N)\) | \(\mathcal{O}(1)\) | All | \(1,000\) readings |
| **Baseline Deviation** | \(\mathcal{O}(N)\) | \(\mathcal{O}(N)\) | \(\mathcal{O}(1)\) | All | \(1,000\) readings |
| **Cumulative Burden** | \(\mathcal{O}(N)\) | \(\mathcal{O}(N)\) | \(\mathcal{O}(1)\) | All | \(1,000\) readings |
| **State Confidence** | \(\mathcal{O}(1)\) | \(\mathcal{O}(1)\) | \(\mathcal{O}(1)\) | All | \(1,000\) readings |
| **Latent State Gating**| \(\mathcal{O}(1)\) | \(\mathcal{O}(1)\) | \(\mathcal{O}(1)\) | All | \(1,000\) readings |
| **Composite Gating** | \(\mathcal{O}(1)\) | \(\mathcal{O}(1)\) | \(\mathcal{O}(1)\) | All | \(1,000\) readings |
| **Risk Synthesis** | \(\mathcal{O}(1)\) | \(\mathcal{O}(1)\) | \(\mathcal{O}(1)\) | All | \(1,000\) readings |
| **Markov Predictor** | \(\mathcal{O}(1)\) | \(\mathcal{O}(1)\) | \(\mathcal{O}(1)\) | All | \(1,000\) readings |
| **Digital Twin Sim** | \(\mathcal{O}(1)\) | \(\mathcal{O}(1)\) | \(\mathcal{O}(1)\) | All | \(1,000\) readings |
| **8-Layer Validator** | \(\mathcal{O}(1)\) | \(\mathcal{O}(1)\) | \(\mathcal{O}(1)\) | All | \(1,000\) readings |

*Table 14.1: Algorithmic Complexity Table*

---

### CHAPTER 14: CONCLUSION

#### Key Engineering Insights
*   All core calculation algorithms operate within linear time boundaries (\(\mathcal{O}(N)\) or \(\mathcal{O}(1)\)).
*   Low memory complexity (\(\mathcal{O}(1)\) or \(\mathcal{O}(N)\)) ensures portability and offline usability.
*   Sorting in the ingestion layer is the only non-linear operation:
    \[\mathcal{O}(N \log N)\quad \text{Equation (14.1)}\]

#### Design Considerations
*   The system must enforce input size constraints (e.g. \(N \le 10,000\) readings) to prevent browser memory fatigue.
*   All calculations must run synchronously to ensure that decision support outputs are available for review.

#### Assumptions
*   It is assumed that the client browser runtime provides adequate memory and processing capacity.
*   It is assumed that the incoming telemetry stream represents a single patient's longitudinal physiological markers.

#### Boundary Conditions
*   If input size exceeds \(10,000\) readings, the ingestion layer rejects the file to prevent browser crashes.
*   Calculations are restricted to the selected observation window.

#### Transition to the Next Chapter
Having detailed the computational complexity, the next chapter will present the calibration theory, error propagation, and sensitivity analysis models.

---

## CHAPTER 15: CALIBRATION THEORY, ERROR PROPAGATION, & SENSITIVITY ANALYSIS

### 15.1 Calibration Theory
The calibration parameters in the TCRE were determined by analyzing homeostatic regulatory dynamics and clinical guidelines:

1.  **Fasting Baseline Target (\(110\) mg/dL):** Mapped to the midpoint of healthy fasting ranges.
2.  **Hyperglycemic Threshold (\(140\) mg/dL):** Mapped to the onset of chronic microvascular damage.
3.  **Rolling Regression Window (\(5\) days):** Configured to filter out high-frequency noise while capturing baseline drifts.
4.  **Raw Risk Weights:** Configured by weighting volatility (\(0.28\)) and silent deterioration (\(0.26\)) to balance acute instability and chronic drift risks.

---

### 15.2 Error Propagation
To evaluate system stability, we model how uncertainty propagates through the reasoning pipeline:

```
Sensor Noise (epsilon) ────> Regression Error (S) ────> Metric Error (VOL)
                                                           │
                                                           ▼
                                                Latent State Uncertainty (SD)
                                                           │
                                                           ▼
                                                Composite State Uncertainty (EC)
                                                           │
                                                           ▼
                                                 Risk Uncertainty (Risk)
                                                           │
                                                           ▼
                                               Recommendation Confidence
```

Let the raw telemetry measurement contains an uncertainty \(\Delta y\). The regression slope error \(\Delta S\) is:
\[\Delta S \propto \frac{\Delta y}{\sum (t_i - \bar{t})^2}\quad \text{Equation (15.1)}\]
The Volatility Index error \(\Delta VOL\) is:
\[\Delta VOL \propto \Delta y\quad \text{Equation (15.2)}\]

The Latent State Score error \(\Delta SD\) is:
\[\Delta SD \le \sum w_j \cdot \Delta Metric_j\quad \text{Equation (15.3)}\]

Finally, the risk score error \(\Delta Risk\) is:
\[\Delta Risk \le \sum w_k \cdot \Delta StateScore_k\quad \text{Equation (15.4)}\]

Because the weighting parameters are less than \(1.0\) and indices are clamped, the pipeline acts as an **uncertainty dampener.** The error at the risk synthesis layer is guaranteed to be less than the combined raw measurement error, maintaining calculation stability.

---

### 15.3 Sensitivity Analysis
To analyze the sensitivity of the temporal metrics, we calculate the partial derivatives of Velocity (\(VI\)) and Volatility (\(VOL\)) under varying noise levels \(\sigma\) and sampling frequencies \(\rho\).

Let the calculated slope \(S\) has a variance:
\[\text{Var}(S) = \frac{\sigma^2}{\sum (t_i - \bar{t})^2}\quad \text{Equation (15.5)}\]

The sensitivity of slope variance to noise \(\sigma^2\) is:
\[\frac{\partial \text{Var}(S)}{\partial \sigma^2} = \frac{1}{\sum (t_i - \bar{t})^2}\quad \text{Equation (15.6)}\]

The sensitivity of slope variance to sampling frequency \(\rho\) is:
\[\frac{\partial \text{Var}(S)}{\partial \rho} \propto -\frac{\sigma^2}{\rho^2}\quad \text{Equation (15.7)}\]

This demonstrates that:
1.  **Noise Sensitivity:** Higher noise \(\sigma^2\) increases slope variance, which can trigger false trend alerts.
2.  **Frequency Sensitivity:** Higher sampling frequency (larger number of points \(t_i\)) reduces slope variance, improving calculation stability.
3.  **Window Sensitivity:** Longer observation windows (larger values of \((t_i - \bar{t})\)) reduce slope variance, filtering out high-frequency noise.

---

### CHAPTER 15: CONCLUSION

#### Key Engineering Insights
*   Slope variance is directly proportional to noise variance and inversely proportional to observation window span.
*   Higher sampling frequency improves slope calculation stability.
*   The pipeline acts as an uncertainty dampener, preventing raw measurement errors from overflowing risk scores.

#### Design Considerations
*   The window size must be configurable to support different biomarker dynamics.
*   The system must monitor data density and flag calculations if density drops.

#### Assumptions
*   It is assumed that physiological noise is zero-mean over long observation windows.
*   It is assumed that the sampling interval is consistent enough to allow calculation of derivatives.

#### Boundary Conditions
*   If sampling density drops below critical limits, the system sets state confidence to low.
*   Outliers are clamped during calculation to prevent mathematical distortion.

#### Transition to the Next Chapter
Having detailed the calibration and sensitivity analysis, the next chapter will present the mathematical justifications and biomarker generalization adapters.

---

## CHAPTER 16: MATHEMATICAL JUSTIFICATIONS & BIOMARKER GENERALIZATION

### 16.1 Design Justifications
The mathematical formulations in the TCRE were selected based on engineering and clinical requirements:

*   **Linear Regression:** Fits a linear model over rolling windows to filter noise and capture baseline trends.
*   **RMSE residuals:** Measures volatility independent of baseline trends, allowing the engine to distinguish stable drift from volatile profiles.
*   **Weighted Sums:** Integrates multiple clinical parameters into unified scores, keeping calculations traceable.
*   **Boolean Gates:** Evaluates eligibility and activation rules using explicit Boolean logic, ensuring determinism.
*   **Markov Chains:** Projects future trajectories based on current metrics, providing clinicians with short-term forecasts.
*   **Digital Twin Utility:** Ranks intervention scenarios using weighted utility scores, helping clinicians plan treatment strategies.

---

### 16.2 Biomarker Generalization Blueprint
To adapt the TCRE to different physiological systems, we define a generalization adapter. Swapping configuration thresholds recalibrates the engine for new biomarkers, leaving the mathematical algorithms untouched.

```
                              +---------------------------------------+
                              |         ABSTRACT REASONING CORE       |
                              |   (Calculates abstract VI, AI, VOL)   |
                              +-------------------+-------------------+
                                                  |
                     +----------------------------+----------------------------+
                     |                                                         |
                     v                                                         v
       +-------------+-------------+                             +-------------+-------------+
       |     GLUCOSE ADAPTER         |                             |      RENAL ADAPTER        |
       |  - Target Baseline: 110   |                             |  - Target Baseline: 90    |
       |  - Hyper Limit: 140       |                             |  - Hyper Limit: 120       |
       +---------------------------+                             +---------------------------+
```

This generalization ensures that the same core engine can monitor hepatic, renal, or cardiac telemetry by updating target baselines and normal range limits, supporting multi-organ clinical monitoring.

---

### CHAPTER 16: CONCLUSION

#### Key Engineering Insights
*   Decoupling the mathematical core from biomarker-specific parameters supports multi-organ monitoring.
*   Normalizing all clinical indices to a `[0, 100]` scale ensures consistent downstream risk evaluation.
*   Configurable thresholds allow the engine to be calibrated for different patient populations.

#### Design Considerations
*   Configuration files must be validated for range limits.
*   The system must expose the active configuration in the metadata sheet to support auditability.

#### Assumptions
*   It is assumed that future biomarker inputs can be modeled as time-series datasets.
*   It is assumed that the sampling frequency of future telemetry matches the physiological dynamics of the target organ system.

#### Boundary Conditions
*   Each reasoning cycle is restricted to a single biomarker configuration.
*   If the configuration is changed, all historical timeline states must be recomputed.

#### Transition to the Next Chapter
Having detailed the generalization strategy, the next chapter will present a fully worked numerical example tracing the calculation pipeline.

---

## CHAPTER 17: FULLY WORKED NUMERICAL EXAMPLES

### 17.1 Step-by-Step Telemetry Calculations
To demonstrate the mathematical framework, we trace the calculation pipeline step-by-step using a sample 5-day telemetry dataset.

Let the target biomarker be blood glucose (mg/dL), and the input measurements over 5 days be:
*   **Day 1:** \(\{120,\, 130,\, 125\}\) (Daily Mean \(\bar{y}_1 = 125\))
*   **Day 2:** \(\{130,\, 135,\, 140\}\) (Daily Mean \(\bar{y}_2 = 135\))
*   **Day 3:** \(\{140,\, 145,\, 150\}\) (Daily Mean \(\bar{y}_3 = 145\))
*   **Day 4:** \(\{150,\, 155,\, 160\}\) (Daily Mean \(\bar{y}_4 = 155\))
*   **Day 5:** \(\{160,\, 165,\, 170\}\) (Daily Mean \(\bar{y}_5 = 165\))

#### 17.1.1 Step 1: Calculate Mean and Baseline Deviation
The overall mean glucose \(\mu\) over the 5 days is:
\[\mu = \frac{125 + 135 + 145 + 155 + 165}{5} = 145\text{ mg/dL}\]
The Baseline Deviation Index (BDI) relative to target \(T = 110\) is:
\[BDI_{raw} = \text{clamp}\left(\text{round}\left(\frac{|145 - 110|}{100} \times 100\right), 0, 100\right) = 35\quad \text{Equation (17.1)}\]
\[BDI_{norm} = \text{round}(35 \times 0.92) = 32\quad \text{Equation (17.2)}\]

#### 17.1.2 Step 2: Fit Linear Regression (Slope and Velocity)
We fit a regression line \(\hat{y}(d) = S \cdot d + C\) to the daily averages:
\[d = \{1,\, 2,\, 3,\, 4,\, 5\}\quad \Rightarrow\quad \bar{d} = 3\]
\[\bar{y}_d = \{125,\, 135,\, 145,\, 155,\, 165\}\quad \Rightarrow\quad \bar{y} = 145\]
The slope \(S\) is computed as:
\[S = \frac{(1-3)(125-145) + (2-3)(135-145) + \dots}{(1-3)^2 + (2-3)^2 + \dots} = 10\text{ mg/dL per day}\quad \text{Equation (17.3)}\]
Since the calculated slope \(S = 10\) exceeds the positive bound, it clamps to \(7.5\) mg/dL per day:
\[VI_{raw} = \text{clamp}(\text{round}((7.5 + 5) \times 8), 0, 100) = 100\quad \text{Equation (17.4)}\]
\[VI_{norm} = \text{round}(100 \times 0.9) = 90\quad \text{Equation (17.5)}\]

#### 17.1.3 Step 3: Calculate Volatility (RMSE)
The regression line predictions \(\hat{y}_d\) match the daily averages exactly:
\[\hat{y}_d = \{125,\, 135,\, 145,\, 155,\, 165\}\]
The raw measurements have a standard deviation around these daily averages. The residuals are:
*   Day 1: \(\{-5,\, 5,\, 0\}\)
*   Day 2: \(\{-5,\, 0,\, 5\}\)
*   Day 3: \(\{-5,\, 0,\, 5\}\)
*   Day 4: \(\{-5,\, 0,\, 5\}\)
*   Day 5: \(\{-5,\, 0,\, 5\}\)

The overall residual sum of squares is:
\[\sum (y_i - \hat{y}_i)^2 = 10 \times 25 = 250\quad \text{Equation (17.6)}\]
For \(N = 15\) measurements, the Volatility (RMSE) is:
\[RMSE = \sqrt{\frac{250}{15}} \approx 4.08\text{ mg/dL}\quad \text{Equation (17.7)}\]
The Volatility Index (VOL) is:
\[VOL_{raw} = \text{clamp}\left(\text{round}\left(\frac{4.08}{40} \times 100\right), 0, 100\right) = 10\quad \text{Equation (17.8)}\]
\[VOL_{norm} = \text{round}(10 \times 0.9) = 9\quad \text{Equation (17.9)}\]

#### 17.1.4 Step 4: Calculate Cumulative Burden (CBI)
Measurements exceeding the threshold of \(140\) are:
*   Day 3: \(\{145,\, 150\}\) (Excess: \(5 + 10 = 15\))
*   Day 4: \(\{150,\, 155,\, 160\}\) (Excess: \(10 + 15 + 20 = 45\))
*   Day 5: \(\{160,\, 165,\, 170\}\) (Excess: \(20 + 25 + 30 = 75\))

The overall \(HyperSum = 15 + 45 + 75 = 135\) mg/dL-readings.
For \(N = 15\) measurements, the Cumulative Burden Index (CBI) is:
\[CBI_{raw} = \text{clamp}\left(\text{round}\left(\frac{135}{15 \times 20} \times 100\right), 0, 100\right) = 45\quad \text{Equation (17.10)}\]
\[CBI_{norm} = \text{round}(45 \times 0.85) = 38\quad \text{Equation (17.11)}\]

#### 17.1.5 Step 5: Evaluate Latent States (Silent Deterioration)
We evaluate the *Silent Deterioration* latent state:
*   **Gates:** Slope is `up` (\(VI_{raw} > 40\)), data density is high, span \(\ge 5\) days. (All Gates Met: **Pass**).
*   **Score Calculation:**
    \[SD_{score} = \text{clamp}(45 \cdot 0.6 + 100 \cdot 0.1 + (100 - 10) \cdot 0.3 \cdot 1.0,\, 0,\, 100) = 64\quad \text{Equation (17.12)}\]

Since \(SD_{score} = 64\), the state severity is mapped to **High**.

---

### CHAPTER 17: CONCLUSION

#### Key Engineering Insights
*   Numerical examples trace how raw telemetry is converted into temporal indices and latent state scores.
*   Calculations utilize rolling averages and linear regressions to filter noise and capture baseline trends.
*   Decoupled metrics allow the engine to evaluate baseline shifts and volatility independently.

#### Design Considerations
*   TypeScript implementations must match these numerical trace calculations.
*   Validation test suites must include these numerical examples to verify logic correctness.

#### Assumptions
*   It is assumed that the incoming telemetry stream represents a single patient's longitudinal physiological markers.
*   It is assumed that target clinical guidelines are updated in compliance with medical standards.

#### Boundary Conditions
*   If data density is insufficient, the system flags the metrics as low-confidence.
*   Calculations are restricted to the selected observation window.

#### Transition to the Next Chapter
Having traced a numerical example, the next chapter will present the summary of EITS Volume 2.

---

## CHAPTER 18: SUMMARY

### 18.1 Monograph Synthesis
EITS Volume 2 has formally defined the mathematical and algebraic core of the Temporal Clinical Reasoning Engine (TCRE). Through eighteen chapters, we have:
1.  **Formulated the General Framework:** Defined the mapping operators (\(\Phi, \Theta, \Lambda, \Psi, \Omega\)) and the telemetry mathematical models.
2.  **Standardized Symbols & Dimensions:** Created comprehensive notation and dimensional analysis tables.
3.  **Detailed Gating Logic:** Formulated equations for the temporal indices, latent state gates, composite crisis gates, and risk scores.
4.  **Modeled Predictions & Twins:** Specified the Markov transition probability allocations and Digital Twin utility score weightings.
5.  **Audited Stability & Complexity:** Defined invariants, safes division, computational Big-O boundaries, and numerical stability limits.
6.  **Derived Error Propagation:** Proved that the weighted sum architecture acts as an uncertainty dampener.
7.  **Generalizer Blueprints:** Outlined the biomarker generalization adapter structure.
8.  **Traced Calculations:** Provided step-by-step numerical examples verifying the equations.

### 18.2 Transition to Volume 3
Volume 2 has focused on *how* the TCRE works mathematically.

Volume 3 of the Engineering Invention Technical Specification (EITS) will document the formal clinical rule set and state gating rules. It will provide the specific Boolean logic configurations, patient demographics modifiers, and clinical recommendation prioritization rules that implement the latent state and composite crisis reasoning.

---

### CHAPTER 18: CONCLUSION

#### Key Engineering Insights
*   The TCRE provides a robust, deterministic, and explainable framework for temporal clinical reasoning.
*   Decoupling clinical logic from presentation layers supports modular maintenance and portability.
*   The system is biomarker-agnostic, allowing adaptation to different physiological markers by changing configuration thresholds.

#### Design Considerations
*   Future EITS volumes must maintain absolute consistency with the mathematical boundaries defined in Volume 2.
*   All mathematical formulations in Volume 3 must align with the normalized [0, 100] index scale.

#### Assumptions
*   It is assumed that the reader is familiar with basic signal processing and calculus concepts.
*   It is assumed that target clinical guidelines are updated in compliance with medical standards.

#### Boundary Conditions
*   Volume 2 does not detail specific software files or deployment scripts; it is restricted to the mathematical framework.
*   Changes to the mathematical equations require formal review and approval by the Clinical Safety Board.

#### End of Document
This concludes **EITS Volume 2 – Mathematical Framework & Temporal Reasoning Formalization**. The system specification is ready for Volume 3: Clinical Rule Set and State Gating Specifications.
